NCT06006273 A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors Status RECRUITING Phase PHASE1
NCT05999994 A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer Status RECRUITING Phase PHASE2
NCT05902169 Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM Status RECRUITING Phase PHASE3
NCT05896007 Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT Status RECRUITING Phase PHASE2
NCT05885386 A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL Status UNKNOWN Phase PHASE2
NCT05879367 Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma Status RECRUITING Phase PHASE1
NCT05781321 Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05765812 A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma Status RECRUITING Phase PHASE1/PHASE2
NCT05728619 HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT05698524 A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma Status RECRUITING Phase PHASE1
NCT05691491 Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness Status RECRUITING Phase PHASE1/PHASE2
NCT05685004 Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05663125 LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas Status UNKNOWN Phase PHASE1/PHASE2
NCT05634707 Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT) Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT05629702 ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids Status RECRUITING Phase PHASE2
NCT05600491 A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme Status RECRUITING Phase PHASE3
NCT05588453 Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain Status RECRUITING Phase PHASE1/PHASE2
NCT05440786 CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE2